MOUNTAIN COMMUNITIES — In the past year, two new drugs have been approved for Alzheimer’s: Lecanemab (the most recent) and Aduhelm. Both these drugs received a lot of press upon their approval by the FDA, and both promised that they could slow the progression of Alzheimer’s if given in the early stages. Both drugs are expensive and not covered by insurance. ...

HEALTH & FITNESS — The same risk factors that contribute to making heart disease the leading cause of death worldwide also impact the rising global prevalence of brain disease, including stroke, Alzheimer’s disease and dementia. According to the American Heart Association’s Heart Disease and Stroke Statistics 2022 Update, more than 54 million people had Alzheimer’s disease and other dementias in ...